» Articles » PMID: 12457285

Efficient Gene Transfer into the CNS by Lentiviral Vectors Purified by Anion Exchange Chromatography

Overview
Journal Gene Ther
Date 2002 Nov 29
PMID 12457285
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Lentiviral vectors have been shown to stably transduce dividing and non-dividing target cells in vitro and in vivo. However, in vivo gene transfer applications with viral vectors in the central nervous system require highly efficient vector preparations, because only very small volumes can be injected stereotactically without damage to the brain tissue. Since lentiviral vectors are generated in transient co-transfection systems, viral preparations need to be purified and efficiently concentrated before injection into the brain. We describe an alternative procedure to concentrate lentiviral preparations by binding viral particles to an anion exchange column. Viral particles are eluted with sodium chloride, desalted and further concentrated by ultrafiltration. These vector preparations allowed high levels of gene transfer into terminally differentiated neuronal and glial cells and long-term transgene expression without any signs of acute and long-term toxicity or inflammation. The purification of lentiviral vectors from large-scale preparations by anion exchange chromatography allowed us to concentrate the virus to small volumes and to use these preparations to genetically modified target cells in vivo without signs of acute inflammatory responses.

Citing Articles

Establishment and Characterization of a Stable Producer Cell Line Generation Platform for the Manufacturing of Clinical-Grade Lentiviral Vectors.

Arrasate A, Bravo I, Lopez-Robles C, Arbelaiz-Sarasola A, Ugalde M, Meijueiro M Biomedicines. 2024; 12(10).

PMID: 39457578 PMC: 11504443. DOI: 10.3390/biomedicines12102265.


Implementation of Novel Affinity Ligand for Lentiviral Vector Purification.

Moreira A, Bezemer S, Faria T, Detmers F, Hermans P, Sierkstra L Int J Mol Sci. 2023; 24(4).

PMID: 36834764 PMC: 9966744. DOI: 10.3390/ijms24043354.


Laboratory-Scale Lentiviral Vector Production and Purification for Enhanced and Genetic Engineering.

Soldi M, Sergi Sergi L, Unali G, Kerzel T, Cuccovillo I, Capasso P Mol Ther Methods Clin Dev. 2020; 19:411-425.

PMID: 33294490 PMC: 7683235. DOI: 10.1016/j.omtm.2020.10.009.


Large-Scale Production of Lentiviral Vectors: Current Perspectives and Challenges.

Martinez-Molina E, Chocarro-Wrona C, Martinez-Moreno D, Marchal J, Boulaiz H Pharmaceutics. 2020; 12(11).

PMID: 33153183 PMC: 7693937. DOI: 10.3390/pharmaceutics12111051.


Preclinical Development of Autologous Hematopoietic Stem Cell-Based Gene Therapy for Immune Deficiencies: A Journey from Mouse Cage to Bed Side.

Garcia-Perez L, Ordas A, Cante-Barrett K, Meij P, Pike-Overzet K, Lankester A Pharmaceutics. 2020; 12(6).

PMID: 32545727 PMC: 7357087. DOI: 10.3390/pharmaceutics12060549.